nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—HTR2B—Sorafenib—thyroid cancer	0.164	0.26	CbGbCtD
Clomipramine—ALB—Vandetanib—thyroid cancer	0.107	0.17	CbGbCtD
Clomipramine—HTR2C—Sorafenib—thyroid cancer	0.106	0.169	CbGbCtD
Clomipramine—CYP2C19—Sorafenib—thyroid cancer	0.042	0.0666	CbGbCtD
Clomipramine—CYP1A2—Sorafenib—thyroid cancer	0.0387	0.0615	CbGbCtD
Clomipramine—ABCB1—Sorafenib—thyroid cancer	0.0339	0.0538	CbGbCtD
Clomipramine—CYP3A4—Vandetanib—thyroid cancer	0.0337	0.0534	CbGbCtD
Clomipramine—CYP2D6—Sorafenib—thyroid cancer	0.0319	0.0506	CbGbCtD
Clomipramine—ABCB1—Doxorubicin—thyroid cancer	0.0206	0.0326	CbGbCtD
Clomipramine—CYP3A4—Sorafenib—thyroid cancer	0.0203	0.0322	CbGbCtD
Clomipramine—CYP2D6—Doxorubicin—thyroid cancer	0.0194	0.0307	CbGbCtD
Clomipramine—CYP3A4—Doxorubicin—thyroid cancer	0.0123	0.0195	CbGbCtD
Clomipramine—GSTP1—neck—thyroid cancer	0.000705	0.0955	CbGeAlD
Clomipramine—GSTP1—saliva-secreting gland—thyroid cancer	0.00055	0.0745	CbGeAlD
Clomipramine—HTR6—head—thyroid cancer	0.000452	0.0612	CbGeAlD
Clomipramine—GSTP1—trachea—thyroid cancer	0.000424	0.0574	CbGeAlD
Clomipramine—HRH2—head—thyroid cancer	0.000413	0.056	CbGeAlD
Clomipramine—GSTP1—thyroid gland—thyroid cancer	0.000335	0.0454	CbGeAlD
Clomipramine—HTR2A—neck—thyroid cancer	0.00031	0.042	CbGeAlD
Clomipramine—GSTP1—head—thyroid cancer	0.000298	0.0403	CbGeAlD
Clomipramine—Purpura—Doxorubicin—thyroid cancer	0.000294	0.000937	CcSEcCtD
Clomipramine—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000292	0.000933	CcSEcCtD
Clomipramine—Asthenia—Sorafenib—thyroid cancer	0.000292	0.000931	CcSEcCtD
Clomipramine—Cardiac arrest—Epirubicin—thyroid cancer	0.000291	0.000928	CcSEcCtD
Clomipramine—Cardiac failure—Doxorubicin—thyroid cancer	0.00029	0.000925	CcSEcCtD
Clomipramine—Mood swings—Epirubicin—thyroid cancer	0.00029	0.000924	CcSEcCtD
Clomipramine—HRH2—lymph node—thyroid cancer	0.000289	0.0392	CbGeAlD
Clomipramine—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000289	0.000921	CcSEcCtD
Clomipramine—Pruritus—Sorafenib—thyroid cancer	0.000288	0.000918	CcSEcCtD
Clomipramine—Ataxia—Epirubicin—thyroid cancer	0.000288	0.000917	CcSEcCtD
Clomipramine—Dehydration—Epirubicin—thyroid cancer	0.000284	0.000907	CcSEcCtD
Clomipramine—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000283	0.000903	CcSEcCtD
Clomipramine—Osteoarthritis—Doxorubicin—thyroid cancer	0.000283	0.000903	CcSEcCtD
Clomipramine—Diplopia—Doxorubicin—thyroid cancer	0.000283	0.000903	CcSEcCtD
Clomipramine—Dry skin—Epirubicin—thyroid cancer	0.00028	0.000894	CcSEcCtD
Clomipramine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000279	0.000891	CcSEcCtD
Clomipramine—Affect lability—Doxorubicin—thyroid cancer	0.000279	0.000889	CcSEcCtD
Clomipramine—Migraine—Doxorubicin—thyroid cancer	0.000279	0.000889	CcSEcCtD
Clomipramine—Hypokalaemia—Epirubicin—thyroid cancer	0.000278	0.000888	CcSEcCtD
Clomipramine—Diarrhoea—Sorafenib—thyroid cancer	0.000278	0.000888	CcSEcCtD
Clomipramine—HTR2B—thyroid gland—thyroid cancer	0.000277	0.0375	CbGeAlD
Clomipramine—Breast disorder—Epirubicin—thyroid cancer	0.000276	0.000882	CcSEcCtD
Clomipramine—Gastritis—Epirubicin—thyroid cancer	0.000271	0.000863	CcSEcCtD
Clomipramine—Muscular weakness—Epirubicin—thyroid cancer	0.00027	0.00086	CcSEcCtD
Clomipramine—Cardiac arrest—Doxorubicin—thyroid cancer	0.000269	0.000858	CcSEcCtD
Clomipramine—Dizziness—Sorafenib—thyroid cancer	0.000269	0.000858	CcSEcCtD
Clomipramine—Mood swings—Doxorubicin—thyroid cancer	0.000268	0.000855	CcSEcCtD
Clomipramine—Ataxia—Doxorubicin—thyroid cancer	0.000266	0.000849	CcSEcCtD
Clomipramine—Dysphagia—Epirubicin—thyroid cancer	0.000264	0.000843	CcSEcCtD
Clomipramine—Dehydration—Doxorubicin—thyroid cancer	0.000263	0.00084	CcSEcCtD
Clomipramine—Eosinophilia—Epirubicin—thyroid cancer	0.000262	0.000835	CcSEcCtD
Clomipramine—HTR2C—head—thyroid cancer	0.000261	0.0354	CbGeAlD
Clomipramine—Dry skin—Doxorubicin—thyroid cancer	0.000259	0.000827	CcSEcCtD
Clomipramine—Vomiting—Sorafenib—thyroid cancer	0.000259	0.000825	CcSEcCtD
Clomipramine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000258	0.000825	CcSEcCtD
Clomipramine—Hypokalaemia—Doxorubicin—thyroid cancer	0.000258	0.000822	CcSEcCtD
Clomipramine—Rash—Sorafenib—thyroid cancer	0.000256	0.000818	CcSEcCtD
Clomipramine—Dermatitis—Sorafenib—thyroid cancer	0.000256	0.000817	CcSEcCtD
Clomipramine—Breast disorder—Doxorubicin—thyroid cancer	0.000256	0.000816	CcSEcCtD
Clomipramine—Headache—Sorafenib—thyroid cancer	0.000255	0.000813	CcSEcCtD
Clomipramine—Bronchitis—Epirubicin—thyroid cancer	0.000254	0.000811	CcSEcCtD
Clomipramine—Pancytopenia—Epirubicin—thyroid cancer	0.000251	0.000801	CcSEcCtD
Clomipramine—Gastritis—Doxorubicin—thyroid cancer	0.00025	0.000799	CcSEcCtD
Clomipramine—Muscular weakness—Doxorubicin—thyroid cancer	0.00025	0.000796	CcSEcCtD
Clomipramine—SLC6A4—head—thyroid cancer	0.000248	0.0335	CbGeAlD
Clomipramine—Dysuria—Epirubicin—thyroid cancer	0.000247	0.000789	CcSEcCtD
Clomipramine—HTR2B—head—thyroid cancer	0.000245	0.0332	CbGeAlD
Clomipramine—Dysphagia—Doxorubicin—thyroid cancer	0.000245	0.00078	CcSEcCtD
Clomipramine—Pollakiuria—Epirubicin—thyroid cancer	0.000244	0.000779	CcSEcCtD
Clomipramine—Eosinophilia—Doxorubicin—thyroid cancer	0.000242	0.000773	CcSEcCtD
Clomipramine—Nausea—Sorafenib—thyroid cancer	0.000242	0.000771	CcSEcCtD
Clomipramine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000241	0.00077	CcSEcCtD
Clomipramine—Weight increased—Epirubicin—thyroid cancer	0.000241	0.000767	CcSEcCtD
Clomipramine—Weight decreased—Epirubicin—thyroid cancer	0.000239	0.000763	CcSEcCtD
Clomipramine—Hyperglycaemia—Epirubicin—thyroid cancer	0.000238	0.000761	CcSEcCtD
Clomipramine—Pneumonia—Epirubicin—thyroid cancer	0.000237	0.000756	CcSEcCtD
Clomipramine—Drowsiness—Epirubicin—thyroid cancer	0.000236	0.000752	CcSEcCtD
Clomipramine—Bronchitis—Doxorubicin—thyroid cancer	0.000235	0.00075	CcSEcCtD
Clomipramine—Pancytopenia—Doxorubicin—thyroid cancer	0.000232	0.000741	CcSEcCtD
Clomipramine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000231	0.000737	CcSEcCtD
Clomipramine—Jaundice—Epirubicin—thyroid cancer	0.00023	0.000733	CcSEcCtD
Clomipramine—Conjunctivitis—Epirubicin—thyroid cancer	0.000229	0.000731	CcSEcCtD
Clomipramine—Urinary tract infection—Epirubicin—thyroid cancer	0.000229	0.000731	CcSEcCtD
Clomipramine—Dysuria—Doxorubicin—thyroid cancer	0.000229	0.00073	CcSEcCtD
Clomipramine—Sweating—Epirubicin—thyroid cancer	0.000226	0.000721	CcSEcCtD
Clomipramine—Pollakiuria—Doxorubicin—thyroid cancer	0.000226	0.000721	CcSEcCtD
Clomipramine—Haematuria—Epirubicin—thyroid cancer	0.000225	0.000717	CcSEcCtD
Clomipramine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000223	0.000712	CcSEcCtD
Clomipramine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000223	0.000711	CcSEcCtD
Clomipramine—Weight increased—Doxorubicin—thyroid cancer	0.000223	0.00071	CcSEcCtD
Clomipramine—Epistaxis—Epirubicin—thyroid cancer	0.000222	0.000709	CcSEcCtD
Clomipramine—Weight decreased—Doxorubicin—thyroid cancer	0.000221	0.000706	CcSEcCtD
Clomipramine—Sinusitis—Epirubicin—thyroid cancer	0.000221	0.000705	CcSEcCtD
Clomipramine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000221	0.000704	CcSEcCtD
Clomipramine—Agranulocytosis—Epirubicin—thyroid cancer	0.00022	0.000702	CcSEcCtD
Clomipramine—ADRA2A—trachea—thyroid cancer	0.00022	0.0297	CbGeAlD
Clomipramine—Pneumonia—Doxorubicin—thyroid cancer	0.000219	0.0007	CcSEcCtD
Clomipramine—Drowsiness—Doxorubicin—thyroid cancer	0.000218	0.000696	CcSEcCtD
Clomipramine—SLC6A2—head—thyroid cancer	0.000218	0.0295	CbGeAlD
Clomipramine—Bradycardia—Epirubicin—thyroid cancer	0.000215	0.000687	CcSEcCtD
Clomipramine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000214	0.000682	CcSEcCtD
Clomipramine—Jaundice—Doxorubicin—thyroid cancer	0.000213	0.000678	CcSEcCtD
Clomipramine—Rhinitis—Epirubicin—thyroid cancer	0.000212	0.000677	CcSEcCtD
Clomipramine—Urinary tract infection—Doxorubicin—thyroid cancer	0.000212	0.000676	CcSEcCtD
Clomipramine—Conjunctivitis—Doxorubicin—thyroid cancer	0.000212	0.000676	CcSEcCtD
Clomipramine—Hepatitis—Epirubicin—thyroid cancer	0.000212	0.000675	CcSEcCtD
Clomipramine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000211	0.000672	CcSEcCtD
Clomipramine—Pharyngitis—Epirubicin—thyroid cancer	0.00021	0.00067	CcSEcCtD
Clomipramine—Sweating—Doxorubicin—thyroid cancer	0.000209	0.000667	CcSEcCtD
Clomipramine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000209	0.000667	CcSEcCtD
Clomipramine—GSTP1—lymph node—thyroid cancer	0.000208	0.0282	CbGeAlD
Clomipramine—Haematuria—Doxorubicin—thyroid cancer	0.000208	0.000663	CcSEcCtD
Clomipramine—Connective tissue disorder—Epirubicin—thyroid cancer	0.000208	0.000663	CcSEcCtD
Clomipramine—Urethral disorder—Epirubicin—thyroid cancer	0.000207	0.000662	CcSEcCtD
Clomipramine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000206	0.000658	CcSEcCtD
Clomipramine—Epistaxis—Doxorubicin—thyroid cancer	0.000206	0.000656	CcSEcCtD
Clomipramine—Sinusitis—Doxorubicin—thyroid cancer	0.000205	0.000653	CcSEcCtD
Clomipramine—Visual impairment—Epirubicin—thyroid cancer	0.000204	0.00065	CcSEcCtD
Clomipramine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000204	0.000649	CcSEcCtD
Clomipramine—Bradycardia—Doxorubicin—thyroid cancer	0.000199	0.000636	CcSEcCtD
Clomipramine—Eye disorder—Epirubicin—thyroid cancer	0.000198	0.000631	CcSEcCtD
Clomipramine—Tinnitus—Epirubicin—thyroid cancer	0.000197	0.000629	CcSEcCtD
Clomipramine—Flushing—Epirubicin—thyroid cancer	0.000196	0.000626	CcSEcCtD
Clomipramine—Cardiac disorder—Epirubicin—thyroid cancer	0.000196	0.000626	CcSEcCtD
Clomipramine—Rhinitis—Doxorubicin—thyroid cancer	0.000196	0.000626	CcSEcCtD
Clomipramine—Hepatitis—Doxorubicin—thyroid cancer	0.000196	0.000625	CcSEcCtD
Clomipramine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000195	0.000621	CcSEcCtD
Clomipramine—Pharyngitis—Doxorubicin—thyroid cancer	0.000194	0.00062	CcSEcCtD
Clomipramine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000193	0.000617	CcSEcCtD
Clomipramine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000192	0.000614	CcSEcCtD
Clomipramine—Angiopathy—Epirubicin—thyroid cancer	0.000192	0.000612	CcSEcCtD
Clomipramine—Urethral disorder—Doxorubicin—thyroid cancer	0.000192	0.000612	CcSEcCtD
Clomipramine—Immune system disorder—Epirubicin—thyroid cancer	0.000191	0.00061	CcSEcCtD
Clomipramine—Mediastinal disorder—Epirubicin—thyroid cancer	0.000191	0.000608	CcSEcCtD
Clomipramine—Chills—Epirubicin—thyroid cancer	0.00019	0.000606	CcSEcCtD
Clomipramine—Arrhythmia—Epirubicin—thyroid cancer	0.000189	0.000603	CcSEcCtD
Clomipramine—CYP1A2—thyroid gland—thyroid cancer	0.000189	0.0256	CbGeAlD
Clomipramine—Visual impairment—Doxorubicin—thyroid cancer	0.000189	0.000602	CcSEcCtD
Clomipramine—Alopecia—Epirubicin—thyroid cancer	0.000187	0.000596	CcSEcCtD
Clomipramine—HTR2A—trachea—thyroid cancer	0.000187	0.0253	CbGeAlD
Clomipramine—Mental disorder—Epirubicin—thyroid cancer	0.000185	0.000591	CcSEcCtD
Clomipramine—Malnutrition—Epirubicin—thyroid cancer	0.000184	0.000588	CcSEcCtD
Clomipramine—Eye disorder—Doxorubicin—thyroid cancer	0.000183	0.000584	CcSEcCtD
Clomipramine—Tinnitus—Doxorubicin—thyroid cancer	0.000183	0.000582	CcSEcCtD
Clomipramine—Cardiac disorder—Doxorubicin—thyroid cancer	0.000182	0.00058	CcSEcCtD
Clomipramine—Flushing—Doxorubicin—thyroid cancer	0.000182	0.00058	CcSEcCtD
Clomipramine—Flatulence—Epirubicin—thyroid cancer	0.000182	0.000579	CcSEcCtD
Clomipramine—Tension—Epirubicin—thyroid cancer	0.000181	0.000577	CcSEcCtD
Clomipramine—Dysgeusia—Epirubicin—thyroid cancer	0.00018	0.000575	CcSEcCtD
Clomipramine—Nervousness—Epirubicin—thyroid cancer	0.000179	0.000571	CcSEcCtD
Clomipramine—ALB—lymph node—thyroid cancer	0.000178	0.0242	CbGeAlD
Clomipramine—Back pain—Epirubicin—thyroid cancer	0.000178	0.000568	CcSEcCtD
Clomipramine—Angiopathy—Doxorubicin—thyroid cancer	0.000178	0.000567	CcSEcCtD
Clomipramine—Muscle spasms—Epirubicin—thyroid cancer	0.000177	0.000565	CcSEcCtD
Clomipramine—Immune system disorder—Doxorubicin—thyroid cancer	0.000177	0.000564	CcSEcCtD
Clomipramine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000176	0.000563	CcSEcCtD
Clomipramine—Chills—Doxorubicin—thyroid cancer	0.000176	0.00056	CcSEcCtD
Clomipramine—Arrhythmia—Doxorubicin—thyroid cancer	0.000175	0.000558	CcSEcCtD
Clomipramine—ADRA2A—thyroid gland—thyroid cancer	0.000174	0.0235	CbGeAlD
Clomipramine—Vision blurred—Epirubicin—thyroid cancer	0.000174	0.000554	CcSEcCtD
Clomipramine—Alopecia—Doxorubicin—thyroid cancer	0.000173	0.000552	CcSEcCtD
Clomipramine—HTR2B—lymph node—thyroid cancer	0.000172	0.0233	CbGeAlD
Clomipramine—Mental disorder—Doxorubicin—thyroid cancer	0.000172	0.000547	CcSEcCtD
Clomipramine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000171	0.000545	CcSEcCtD
Clomipramine—Malnutrition—Doxorubicin—thyroid cancer	0.00017	0.000544	CcSEcCtD
Clomipramine—Anaemia—Epirubicin—thyroid cancer	0.00017	0.000543	CcSEcCtD
Clomipramine—Agitation—Epirubicin—thyroid cancer	0.000169	0.00054	CcSEcCtD
Clomipramine—Flatulence—Doxorubicin—thyroid cancer	0.000168	0.000536	CcSEcCtD
Clomipramine—Tension—Doxorubicin—thyroid cancer	0.000167	0.000533	CcSEcCtD
Clomipramine—Dysgeusia—Doxorubicin—thyroid cancer	0.000167	0.000532	CcSEcCtD
Clomipramine—Malaise—Epirubicin—thyroid cancer	0.000166	0.00053	CcSEcCtD
Clomipramine—Nervousness—Doxorubicin—thyroid cancer	0.000166	0.000528	CcSEcCtD
Clomipramine—Vertigo—Epirubicin—thyroid cancer	0.000165	0.000528	CcSEcCtD
Clomipramine—Syncope—Epirubicin—thyroid cancer	0.000165	0.000527	CcSEcCtD
Clomipramine—Leukopenia—Epirubicin—thyroid cancer	0.000165	0.000526	CcSEcCtD
Clomipramine—Back pain—Doxorubicin—thyroid cancer	0.000165	0.000526	CcSEcCtD
Clomipramine—Muscle spasms—Doxorubicin—thyroid cancer	0.000164	0.000523	CcSEcCtD
Clomipramine—Palpitations—Epirubicin—thyroid cancer	0.000163	0.000519	CcSEcCtD
Clomipramine—Loss of consciousness—Epirubicin—thyroid cancer	0.000162	0.000516	CcSEcCtD
Clomipramine—Cough—Epirubicin—thyroid cancer	0.000161	0.000513	CcSEcCtD
Clomipramine—Vision blurred—Doxorubicin—thyroid cancer	0.000161	0.000512	CcSEcCtD
Clomipramine—Convulsion—Epirubicin—thyroid cancer	0.00016	0.000509	CcSEcCtD
Clomipramine—Hypertension—Epirubicin—thyroid cancer	0.000159	0.000507	CcSEcCtD
Clomipramine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000158	0.000504	CcSEcCtD
Clomipramine—Anaemia—Doxorubicin—thyroid cancer	0.000158	0.000502	CcSEcCtD
Clomipramine—Myalgia—Epirubicin—thyroid cancer	0.000157	0.0005	CcSEcCtD
Clomipramine—Arthralgia—Epirubicin—thyroid cancer	0.000157	0.0005	CcSEcCtD
Clomipramine—Chest pain—Epirubicin—thyroid cancer	0.000157	0.0005	CcSEcCtD
Clomipramine—Agitation—Doxorubicin—thyroid cancer	0.000157	0.0005	CcSEcCtD
Clomipramine—Anxiety—Epirubicin—thyroid cancer	0.000156	0.000498	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000156	0.000497	CcSEcCtD
Clomipramine—Discomfort—Epirubicin—thyroid cancer	0.000155	0.000494	CcSEcCtD
Clomipramine—ADRA2A—head—thyroid cancer	0.000154	0.0209	CbGeAlD
Clomipramine—Malaise—Doxorubicin—thyroid cancer	0.000154	0.00049	CcSEcCtD
Clomipramine—Dry mouth—Epirubicin—thyroid cancer	0.000153	0.000489	CcSEcCtD
Clomipramine—Vertigo—Doxorubicin—thyroid cancer	0.000153	0.000488	CcSEcCtD
Clomipramine—Syncope—Doxorubicin—thyroid cancer	0.000153	0.000488	CcSEcCtD
Clomipramine—SLC6A2—lymph node—thyroid cancer	0.000153	0.0207	CbGeAlD
Clomipramine—Leukopenia—Doxorubicin—thyroid cancer	0.000153	0.000487	CcSEcCtD
Clomipramine—Confusional state—Epirubicin—thyroid cancer	0.000152	0.000484	CcSEcCtD
Clomipramine—Palpitations—Doxorubicin—thyroid cancer	0.000151	0.00048	CcSEcCtD
Clomipramine—Oedema—Epirubicin—thyroid cancer	0.00015	0.00048	CcSEcCtD
Clomipramine—Anaphylactic shock—Epirubicin—thyroid cancer	0.00015	0.00048	CcSEcCtD
Clomipramine—Loss of consciousness—Doxorubicin—thyroid cancer	0.00015	0.000478	CcSEcCtD
Clomipramine—Cough—Doxorubicin—thyroid cancer	0.000149	0.000474	CcSEcCtD
Clomipramine—Shock—Epirubicin—thyroid cancer	0.000148	0.000472	CcSEcCtD
Clomipramine—Convulsion—Doxorubicin—thyroid cancer	0.000148	0.000471	CcSEcCtD
Clomipramine—Nervous system disorder—Epirubicin—thyroid cancer	0.000147	0.00047	CcSEcCtD
Clomipramine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000147	0.00047	CcSEcCtD
Clomipramine—Hypertension—Doxorubicin—thyroid cancer	0.000147	0.000469	CcSEcCtD
Clomipramine—Tachycardia—Epirubicin—thyroid cancer	0.000147	0.000468	CcSEcCtD
Clomipramine—Skin disorder—Epirubicin—thyroid cancer	0.000146	0.000466	CcSEcCtD
Clomipramine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000145	0.000464	CcSEcCtD
Clomipramine—Myalgia—Doxorubicin—thyroid cancer	0.000145	0.000463	CcSEcCtD
Clomipramine—Arthralgia—Doxorubicin—thyroid cancer	0.000145	0.000463	CcSEcCtD
Clomipramine—Chest pain—Doxorubicin—thyroid cancer	0.000145	0.000463	CcSEcCtD
Clomipramine—Anxiety—Doxorubicin—thyroid cancer	0.000145	0.000461	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000144	0.00046	CcSEcCtD
Clomipramine—Discomfort—Doxorubicin—thyroid cancer	0.000143	0.000457	CcSEcCtD
Clomipramine—Anorexia—Epirubicin—thyroid cancer	0.000143	0.000457	CcSEcCtD
Clomipramine—Dry mouth—Doxorubicin—thyroid cancer	0.000142	0.000453	CcSEcCtD
Clomipramine—Hypotension—Epirubicin—thyroid cancer	0.00014	0.000448	CcSEcCtD
Clomipramine—Confusional state—Doxorubicin—thyroid cancer	0.00014	0.000447	CcSEcCtD
Clomipramine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000139	0.000444	CcSEcCtD
Clomipramine—Oedema—Doxorubicin—thyroid cancer	0.000139	0.000444	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000137	0.000437	CcSEcCtD
Clomipramine—Shock—Doxorubicin—thyroid cancer	0.000137	0.000437	CcSEcCtD
Clomipramine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000136	0.000435	CcSEcCtD
Clomipramine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000136	0.000434	CcSEcCtD
Clomipramine—Insomnia—Epirubicin—thyroid cancer	0.000136	0.000434	CcSEcCtD
Clomipramine—Tachycardia—Doxorubicin—thyroid cancer	0.000136	0.000433	CcSEcCtD
Clomipramine—Skin disorder—Doxorubicin—thyroid cancer	0.000135	0.000431	CcSEcCtD
Clomipramine—Paraesthesia—Epirubicin—thyroid cancer	0.000135	0.000431	CcSEcCtD
Clomipramine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000134	0.000429	CcSEcCtD
Clomipramine—Dyspnoea—Epirubicin—thyroid cancer	0.000134	0.000428	CcSEcCtD
Clomipramine—Somnolence—Epirubicin—thyroid cancer	0.000134	0.000426	CcSEcCtD
Clomipramine—Anorexia—Doxorubicin—thyroid cancer	0.000133	0.000423	CcSEcCtD
Clomipramine—Dyspepsia—Epirubicin—thyroid cancer	0.000132	0.000422	CcSEcCtD
Clomipramine—HTR2A—head—thyroid cancer	0.000131	0.0177	CbGeAlD
Clomipramine—Decreased appetite—Epirubicin—thyroid cancer	0.000131	0.000417	CcSEcCtD
Clomipramine—Hypotension—Doxorubicin—thyroid cancer	0.00013	0.000415	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00013	0.000414	CcSEcCtD
Clomipramine—Fatigue—Epirubicin—thyroid cancer	0.00013	0.000413	CcSEcCtD
Clomipramine—Pain—Epirubicin—thyroid cancer	0.000129	0.00041	CcSEcCtD
Clomipramine—Constipation—Epirubicin—thyroid cancer	0.000129	0.00041	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000127	0.000404	CcSEcCtD
Clomipramine—Insomnia—Doxorubicin—thyroid cancer	0.000126	0.000401	CcSEcCtD
Clomipramine—Paraesthesia—Doxorubicin—thyroid cancer	0.000125	0.000398	CcSEcCtD
Clomipramine—Dyspnoea—Doxorubicin—thyroid cancer	0.000124	0.000396	CcSEcCtD
Clomipramine—Feeling abnormal—Epirubicin—thyroid cancer	0.000124	0.000395	CcSEcCtD
Clomipramine—Somnolence—Doxorubicin—thyroid cancer	0.000124	0.000394	CcSEcCtD
Clomipramine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000123	0.000392	CcSEcCtD
Clomipramine—Dyspepsia—Doxorubicin—thyroid cancer	0.000122	0.000391	CcSEcCtD
Clomipramine—ABCB1—trachea—thyroid cancer	0.000122	0.0166	CbGeAlD
Clomipramine—Decreased appetite—Doxorubicin—thyroid cancer	0.000121	0.000386	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00012	0.000383	CcSEcCtD
Clomipramine—Fatigue—Doxorubicin—thyroid cancer	0.00012	0.000383	CcSEcCtD
Clomipramine—Urticaria—Epirubicin—thyroid cancer	0.000119	0.000381	CcSEcCtD
Clomipramine—CYP2D6—head—thyroid cancer	0.000119	0.0162	CbGeAlD
Clomipramine—Pain—Doxorubicin—thyroid cancer	0.000119	0.000379	CcSEcCtD
Clomipramine—Constipation—Doxorubicin—thyroid cancer	0.000119	0.000379	CcSEcCtD
Clomipramine—Body temperature increased—Epirubicin—thyroid cancer	0.000119	0.000379	CcSEcCtD
Clomipramine—Abdominal pain—Epirubicin—thyroid cancer	0.000119	0.000379	CcSEcCtD
Clomipramine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000115	0.000366	CcSEcCtD
Clomipramine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000114	0.000363	CcSEcCtD
Clomipramine—Hypersensitivity—Epirubicin—thyroid cancer	0.000111	0.000353	CcSEcCtD
Clomipramine—Urticaria—Doxorubicin—thyroid cancer	0.00011	0.000352	CcSEcCtD
Clomipramine—Body temperature increased—Doxorubicin—thyroid cancer	0.00011	0.000351	CcSEcCtD
Clomipramine—Abdominal pain—Doxorubicin—thyroid cancer	0.00011	0.000351	CcSEcCtD
Clomipramine—ADRA2A—lymph node—thyroid cancer	0.000108	0.0146	CbGeAlD
Clomipramine—Asthenia—Epirubicin—thyroid cancer	0.000108	0.000344	CcSEcCtD
Clomipramine—Pruritus—Epirubicin—thyroid cancer	0.000106	0.000339	CcSEcCtD
Clomipramine—Diarrhoea—Epirubicin—thyroid cancer	0.000103	0.000328	CcSEcCtD
Clomipramine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000102	0.000327	CcSEcCtD
Clomipramine—Asthenia—Doxorubicin—thyroid cancer	9.98e-05	0.000318	CcSEcCtD
Clomipramine—Dizziness—Epirubicin—thyroid cancer	9.94e-05	0.000317	CcSEcCtD
Clomipramine—Pruritus—Doxorubicin—thyroid cancer	9.84e-05	0.000314	CcSEcCtD
Clomipramine—ABCB1—thyroid gland—thyroid cancer	9.68e-05	0.0131	CbGeAlD
Clomipramine—Vomiting—Epirubicin—thyroid cancer	9.56e-05	0.000305	CcSEcCtD
Clomipramine—Diarrhoea—Doxorubicin—thyroid cancer	9.52e-05	0.000304	CcSEcCtD
Clomipramine—Rash—Epirubicin—thyroid cancer	9.48e-05	0.000302	CcSEcCtD
Clomipramine—Dermatitis—Epirubicin—thyroid cancer	9.47e-05	0.000302	CcSEcCtD
Clomipramine—Headache—Epirubicin—thyroid cancer	9.42e-05	0.0003	CcSEcCtD
Clomipramine—Dizziness—Doxorubicin—thyroid cancer	9.2e-05	0.000293	CcSEcCtD
Clomipramine—Nausea—Epirubicin—thyroid cancer	8.93e-05	0.000285	CcSEcCtD
Clomipramine—Vomiting—Doxorubicin—thyroid cancer	8.84e-05	0.000282	CcSEcCtD
Clomipramine—Rash—Doxorubicin—thyroid cancer	8.77e-05	0.00028	CcSEcCtD
Clomipramine—Dermatitis—Doxorubicin—thyroid cancer	8.76e-05	0.000279	CcSEcCtD
Clomipramine—Headache—Doxorubicin—thyroid cancer	8.71e-05	0.000278	CcSEcCtD
Clomipramine—ABCB1—head—thyroid cancer	8.58e-05	0.0116	CbGeAlD
Clomipramine—Nausea—Doxorubicin—thyroid cancer	8.26e-05	0.000264	CcSEcCtD
Clomipramine—ABCB1—lymph node—thyroid cancer	6.01e-05	0.00814	CbGeAlD
Clomipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	3.8e-05	0.000777	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PRKAR1A—thyroid cancer	3.79e-05	0.000775	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—CALCA—thyroid cancer	3.76e-05	0.00077	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CDK1—thyroid cancer	3.72e-05	0.000762	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—IFNA2—thyroid cancer	3.72e-05	0.000761	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—NDUFA13—thyroid cancer	3.72e-05	0.000761	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.7e-05	0.000757	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TCF7L1—thyroid cancer	3.68e-05	0.000754	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—HPGD—thyroid cancer	3.62e-05	0.00074	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MEN1—thyroid cancer	3.62e-05	0.00074	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PTCH1—thyroid cancer	3.58e-05	0.000733	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—CDK1—thyroid cancer	3.56e-05	0.000729	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—SST—thyroid cancer	3.56e-05	0.000728	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—SST—thyroid cancer	3.55e-05	0.000726	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—HPGD—thyroid cancer	3.53e-05	0.000723	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—PTCH1—thyroid cancer	3.53e-05	0.000722	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CHST14—thyroid cancer	3.5e-05	0.000716	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—PPARG—thyroid cancer	3.5e-05	0.000716	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—CALCA—thyroid cancer	3.42e-05	0.0007	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—CALCA—thyroid cancer	3.42e-05	0.000699	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	3.41e-05	0.000697	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MINPP1—thyroid cancer	3.38e-05	0.000691	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TCF7L1—thyroid cancer	3.35e-05	0.000686	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—HPGD—thyroid cancer	3.33e-05	0.000681	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	3.3e-05	0.000675	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SST—thyroid cancer	3.28e-05	0.000671	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PTCH1—thyroid cancer	3.27e-05	0.000669	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.27e-05	0.000669	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.24e-05	0.000663	CbGpPWpGaD
Clomipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	3.23e-05	0.000661	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—SST—thyroid cancer	3.23e-05	0.000661	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CALCA—thyroid cancer	3.16e-05	0.000646	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.11e-05	0.000636	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CALCA—thyroid cancer	3.11e-05	0.000636	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TSHR—thyroid cancer	3.1e-05	0.000635	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—CDK1—thyroid cancer	3.09e-05	0.000633	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	3.08e-05	0.00063	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PRKAR1A—thyroid cancer	3.05e-05	0.000625	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SST—thyroid cancer	2.99e-05	0.000612	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—NRG1—thyroid cancer	2.99e-05	0.000612	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.97e-05	0.000608	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.94e-05	0.000601	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—TPR—thyroid cancer	2.93e-05	0.0006	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MEN1—thyroid cancer	2.92e-05	0.000597	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PRKAR1A—thyroid cancer	2.89e-05	0.00059	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CALCA—thyroid cancer	2.88e-05	0.000589	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.87e-05	0.000587	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CDK1—thyroid cancer	2.86e-05	0.000585	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—HPGD—thyroid cancer	2.82e-05	0.000577	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CDK1—thyroid cancer	2.81e-05	0.000576	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	2.8e-05	0.000574	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—PTGS2—thyroid cancer	2.75e-05	0.000563	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.72e-05	0.000557	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CHST14—thyroid cancer	2.7e-05	0.000552	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TSHR—thyroid cancer	2.7e-05	0.000552	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TERT—thyroid cancer	2.68e-05	0.000549	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PRKAR1A—thyroid cancer	2.65e-05	0.000543	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PTCH1—thyroid cancer	2.64e-05	0.00054	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CDK1—thyroid cancer	2.61e-05	0.000534	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HIF1A—thyroid cancer	2.57e-05	0.000525	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MEN1—thyroid cancer	2.53e-05	0.000519	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TSHR—thyroid cancer	2.45e-05	0.000502	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SST—thyroid cancer	2.41e-05	0.000494	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PRKAR1A—thyroid cancer	2.41e-05	0.000494	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—PTEN—thyroid cancer	2.4e-05	0.000491	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CALCA—thyroid cancer	2.32e-05	0.000476	CbGpPWpGaD
Clomipramine—ALB—Metabolism—TPR—thyroid cancer	2.32e-05	0.000474	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MEN1—thyroid cancer	2.31e-05	0.000472	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NRG1—thyroid cancer	2.29e-05	0.000469	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PTCH1—thyroid cancer	2.29e-05	0.000469	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.29e-05	0.000468	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.28e-05	0.000467	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PRKAR1A—thyroid cancer	2.28e-05	0.000466	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—NRAS—thyroid cancer	2.26e-05	0.000463	CbGpPWpGaD
Clomipramine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.2e-05	0.000451	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—SLC5A5—thyroid cancer	2.2e-05	0.000449	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—HPGD—thyroid cancer	2.18e-05	0.000445	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—BRAF—thyroid cancer	2.13e-05	0.000435	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CDK1—thyroid cancer	2.1e-05	0.00043	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SST—thyroid cancer	2.1e-05	0.000429	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NRG1—thyroid cancer	2.09e-05	0.000428	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PTCH1—thyroid cancer	2.09e-05	0.000427	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—TPR—thyroid cancer	2.08e-05	0.000425	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.06e-05	0.000422	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TERT—thyroid cancer	2.06e-05	0.000421	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	2.04e-05	0.000418	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—TPR—thyroid cancer	2.03e-05	0.000415	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.03e-05	0.000415	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CALCA—thyroid cancer	2.02e-05	0.000413	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	2e-05	0.000408	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HIF1A—thyroid cancer	1.97e-05	0.000403	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—KRAS—thyroid cancer	1.95e-05	0.000398	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—TPR—thyroid cancer	1.91e-05	0.000391	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SST—thyroid cancer	1.91e-05	0.00039	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.88e-05	0.000385	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TERT—thyroid cancer	1.88e-05	0.000385	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.85e-05	0.000379	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—RXRA—thyroid cancer	1.85e-05	0.000377	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CALCA—thyroid cancer	1.84e-05	0.000376	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CDK1—thyroid cancer	1.83e-05	0.000374	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HIF1A—thyroid cancer	1.8e-05	0.000368	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—NRAS—thyroid cancer	1.76e-05	0.00036	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.74e-05	0.000356	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—NRAS—thyroid cancer	1.73e-05	0.000355	CbGpPWpGaD
Clomipramine—ALB—Metabolism—SLC5A5—thyroid cancer	1.73e-05	0.000355	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.71e-05	0.00035	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NRG1—thyroid cancer	1.69e-05	0.000346	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CDK1—thyroid cancer	1.66e-05	0.00034	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—HRAS—thyroid cancer	1.65e-05	0.000339	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—BRAF—thyroid cancer	1.63e-05	0.000334	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.62e-05	0.000332	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—TPR—thyroid cancer	1.62e-05	0.000331	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—AKT1—thyroid cancer	1.61e-05	0.000329	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.59e-05	0.000326	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—NRAS—thyroid cancer	1.58e-05	0.000324	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.56e-05	0.000318	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CCND1—thyroid cancer	1.55e-05	0.000317	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.52e-05	0.000311	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TERT—thyroid cancer	1.52e-05	0.00031	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—KRAS—thyroid cancer	1.51e-05	0.00031	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PTEN—thyroid cancer	1.5e-05	0.000306	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—KRAS—thyroid cancer	1.49e-05	0.000305	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—BRAF—thyroid cancer	1.49e-05	0.000305	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NRG1—thyroid cancer	1.47e-05	0.0003	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—AKT1—thyroid cancer	1.46e-05	0.000299	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.46e-05	0.000298	CbGpPWpGaD
Clomipramine—ALB—Metabolism—RXRA—thyroid cancer	1.46e-05	0.000298	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HIF1A—thyroid cancer	1.45e-05	0.000297	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.44e-05	0.000295	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.43e-05	0.000293	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.42e-05	0.00029	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—NRAS—thyroid cancer	1.39e-05	0.000284	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—AKT1—thyroid cancer	1.38e-05	0.000283	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—KRAS—thyroid cancer	1.36e-05	0.000279	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—TP53—thyroid cancer	1.35e-05	0.000275	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—NRAS—thyroid cancer	1.34e-05	0.000273	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	1.33e-05	0.000273	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TERT—thyroid cancer	1.32e-05	0.000269	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—RXRA—thyroid cancer	1.31e-05	0.000267	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—HRAS—thyroid cancer	1.29e-05	0.000263	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—NRAS—thyroid cancer	1.28e-05	0.000261	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—RXRA—thyroid cancer	1.28e-05	0.000261	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.27e-05	0.00026	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—HRAS—thyroid cancer	1.27e-05	0.00026	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HIF1A—thyroid cancer	1.26e-05	0.000258	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—TPR—thyroid cancer	1.25e-05	0.000256	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—AKT1—thyroid cancer	1.23e-05	0.000252	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.23e-05	0.000252	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.21e-05	0.000248	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—RXRA—thyroid cancer	1.2e-05	0.000246	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—BRAF—thyroid cancer	1.2e-05	0.000246	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TERT—thyroid cancer	1.2e-05	0.000245	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—KRAS—thyroid cancer	1.19e-05	0.000244	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CCND1—thyroid cancer	1.19e-05	0.000243	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PPARG—thyroid cancer	1.16e-05	0.000238	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—HRAS—thyroid cancer	1.16e-05	0.000237	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—KRAS—thyroid cancer	1.15e-05	0.000235	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PTEN—thyroid cancer	1.15e-05	0.000235	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	1.15e-05	0.000234	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—AKT1—thyroid cancer	1.14e-05	0.000232	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.14e-05	0.000232	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—AKT1—thyroid cancer	1.13e-05	0.00023	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—AKT1—thyroid cancer	1.12e-05	0.000229	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	1.11e-05	0.000227	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	1.1e-05	0.000225	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CCND1—thyroid cancer	1.09e-05	0.000222	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TP53—thyroid cancer	1.06e-05	0.000217	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PTEN—thyroid cancer	1.05e-05	0.000215	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—BRAF—thyroid cancer	1.04e-05	0.000213	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NRAS—thyroid cancer	1.02e-05	0.00021	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—AKT1—thyroid cancer	1.02e-05	0.000209	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TP53—thyroid cancer	1.02e-05	0.000209	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—RXRA—thyroid cancer	1.02e-05	0.000208	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—HRAS—thyroid cancer	1.02e-05	0.000208	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	1.01e-05	0.000206	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.91e-06	0.000203	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HRAS—thyroid cancer	9.77e-06	0.0002	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	9.55e-06	0.000195	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	9.49e-06	0.000194	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	9.36e-06	0.000191	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NRAS—thyroid cancer	9.35e-06	0.000191	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	9.35e-06	0.000191	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PPARG—thyroid cancer	9.19e-06	0.000188	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTGS2—thyroid cancer	9.16e-06	0.000187	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	9.09e-06	0.000186	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—AKT1—thyroid cancer	8.97e-06	0.000183	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—KRAS—thyroid cancer	8.82e-06	0.00018	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCND1—thyroid cancer	8.76e-06	0.000179	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	8.69e-06	0.000178	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AKT1—thyroid cancer	8.63e-06	0.000177	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PTEN—thyroid cancer	8.46e-06	0.000173	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PPARG—thyroid cancer	8.25e-06	0.000169	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	8.25e-06	0.000169	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	8.12e-06	0.000166	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PPARG—thyroid cancer	8.06e-06	0.000165	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—KRAS—thyroid cancer	8.05e-06	0.000165	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTEN—thyroid cancer	7.99e-06	0.000164	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	7.89e-06	0.000161	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—RXRA—thyroid cancer	7.86e-06	0.000161	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TP53—thyroid cancer	7.84e-06	0.00016	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCND1—thyroid cancer	7.61e-06	0.000156	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PPARG—thyroid cancer	7.59e-06	0.000155	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NRAS—thyroid cancer	7.55e-06	0.000154	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HRAS—thyroid cancer	7.5e-06	0.000153	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	7.38e-06	0.000151	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PTEN—thyroid cancer	7.35e-06	0.00015	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTGS2—thyroid cancer	7.23e-06	0.000148	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	7.18e-06	0.000147	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	7.17e-06	0.000147	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TP53—thyroid cancer	7.16e-06	0.000146	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	6.92e-06	0.000142	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HRAS—thyroid cancer	6.84e-06	0.00014	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	6.68e-06	0.000137	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AKT1—thyroid cancer	6.62e-06	0.000135	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NRAS—thyroid cancer	6.55e-06	0.000134	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	6.52e-06	0.000133	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—KRAS—thyroid cancer	6.5e-06	0.000133	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTGS2—thyroid cancer	6.49e-06	0.000133	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PPARG—thyroid cancer	6.43e-06	0.000132	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTGS2—thyroid cancer	6.34e-06	0.00013	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTEN—thyroid cancer	6.31e-06	0.000129	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AKT1—thyroid cancer	6.04e-06	0.000124	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTGS2—thyroid cancer	5.97e-06	0.000122	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	5.96e-06	0.000122	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TP53—thyroid cancer	5.77e-06	0.000118	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTEN—thyroid cancer	5.66e-06	0.000116	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—KRAS—thyroid cancer	5.64e-06	0.000115	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTEN—thyroid cancer	5.53e-06	0.000113	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HRAS—thyroid cancer	5.52e-06	0.000113	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTEN—thyroid cancer	5.21e-06	0.000107	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	5.13e-06	0.000105	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTGS2—thyroid cancer	5.06e-06	0.000104	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TP53—thyroid cancer	5.01e-06	0.000103	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PPARG—thyroid cancer	4.96e-06	0.000102	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AKT1—thyroid cancer	4.87e-06	9.97e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HRAS—thyroid cancer	4.79e-06	9.81e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—AKT1—thyroid cancer	4.61e-06	9.42e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TP53—thyroid cancer	4.56e-06	9.33e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTEN—thyroid cancer	4.41e-06	9.03e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	4.36e-06	8.92e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AKT1—thyroid cancer	4.23e-06	8.66e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTGS2—thyroid cancer	3.9e-06	7.99e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	3.85e-06	7.88e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—AKT1—thyroid cancer	3.63e-06	7.44e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTEN—thyroid cancer	3.4e-06	6.97e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—AKT1—thyroid cancer	3.26e-06	6.68e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—AKT1—thyroid cancer	3.18e-06	6.52e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—AKT1—thyroid cancer	3e-06	6.14e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AKT1—thyroid cancer	2.54e-06	5.2e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AKT1—thyroid cancer	1.96e-06	4.01e-05	CbGpPWpGaD
